Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2023

Mavragani CP, Kirou KA, Seshan SV, Crow MK. Type I interferon and neutrophil transcripts in lupus nephritis renal biopsies: clinical and histopathological associations. Rheumatology (Oxford). 2023;62(7):2534-2538.

Kim JW, McKay RR, Radke MR, Zhao S, Taplin M-, Davis NB, et al. Randomized Trial of Olaparib With or Without Cediranib for Metastatic Castration-Resistant Prostate Cancer: The Results From National Cancer Institute 9984. J Clin Oncol. 2023;41(4):871-880.

Mesa KR, O'Connor KA, Ng C, Salvatore SP, Littman DR. Niche-specific macrophage loss promotes skin capillary aging. bioRxiv. 2023.

Hao Y, Lynch K, Fan P, Jurtschenko C, Cid M, Zhao Z, et al. Development of a Machine Learning Algorithm for Drug Screening Analysis on High-Resolution UPLC-MSE/QTOF Mass Spectrometry. J Appl Lab Med. 2023;8(1):53-66.

Liu D, Cheng Y, Zhou H, Wang L, Fiel RH, Gruenstein Y, et al. Early Introduction and Community Transmission of SARS-CoV-2 Omicron Variant, New York, New York, USA. Emerg Infect Dis. 2023;29(2):371-380.

Barone P, Patel S. Myelodysplastic syndrome: Approach to diagnosis in the era of personalized medicine. Semin Diagn Pathol. 2023;40(3):172-181.

Alhomoud M, Magro C, Seshan S, Zhang T, Gomez-Arteaga A, Chokr N, et al. Deposition of complement components C5b-9 and MASP2 in tissues is not a feature of GVHD and may assist in discriminating GVHD from thrombotic microangiopathy following allogenic transplantation. Bone Marrow Transplant. 2023;58(11):1270-1274.

Pan E, Xie W, Ajmera A, Araneta A, Jamieson C, Folefac E, et al. A Phase I Study of Combination Olaparib and Radium-223 in Men with Metastatic Castration-Resistant Prostate Cancer (mCRPC) with Bone Metastases (COMRADE). Mol Cancer Ther. 2023;22(4):511-518.

Chung EY, Sartori G, Ponzoni M, Cascione L, Priebe V, Xu-Monette ZY, et al. ETS1 phosphorylation at threonine 38 is associated with the cell of origin of diffuse large B cell lymphoma and sustains the growth of tumour cells. Br J Haematol. 2023;203(2):244-254.

Yallowitz AR, Shim J-, Xu R, Greenblatt MB. An angiogenic approach to osteoanabolic therapy targeting the SHN3-SLIT3 pathway. Bone. 2023;172:116761.